Dashboard
Manage Tickers

ERNAEterna Therapeutics Inc.

Nasdaq brooklynitx.com


$ 2.09 $ -0.14 (-6.48 %)    

Friday, 10-May-2024 12:37:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 2.0201
$ 2.09
$ 0.00 x 0
$ 0.00 x 0
$ 2.09 - $ 2.09
$ 0.84 - $ 2.99
4,248
na
10.73M
$ 5.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-14-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-20-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 07-01-2022 03-31-2022 10-Q
9 04-15-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-20-2020 03-31-2020 10-Q
17 03-19-2020 12-31-2019 10-K
18 11-01-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-22-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-06-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 03-09-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-09-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-27-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eterna-therapeutics-presents-development-of-beta-2-microglobulin-knockout-imsc-line-with-enhanced-immunosuppressive-activity-and-stealthing-features-that-may-further-augment-the-therapeutic-potential-of-mscs-in-inflammatory-diseases-at-the-asgct-annual-meeting
Eterna Therapeutics Presents Development O...
05/10/2024 12:07:01

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive ...

eterna-therapeutics-to-present-at-the-asgct-27th-annual-meeting-on-development-of-beta-2-microglobulin-knockout-imsc-line-with-enhanced-immunosuppressive-activity-and-stealthing-features-that-may-further-augment-the-therapeutic-potential-of-mscs-in-inflammatory-diseases
Eterna Therapeutics To Present at The ASGC...
05/07/2024 12:04:55

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive ...

eterna-therapeutics-inc-on-march-19-received-a-notice-from-nasdaq-stating-that-co-is-not-in-compliance-with-nasdaq-listing-rule-5550b1
Eterna Therapeutics Inc On March 19, Recei...
03/22/2024 20:37:23

-SEC Filing

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/02/2024 13:06:01

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/01/2024 13:06:10

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/21/2023 13:07:41

eterna-therapeutics-appointed-sanjeev-luther-as-president-and-ceo-succeeds-matt-angel-effective-jan-1-2024
Eterna Therapeutics Appointed Sanjeev Luth...
12/20/2023 21:17:00

eterna-therapeutics-13g-filing-shows-iaf-llc-reported-a-999-passive-stake-in-the-co-as-of-dec-14
Eterna Therapeutics 13G Filing Shows IAF, ...
12/20/2023 20:28:19

- SEC Filing

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/20/2023 13:07:08

eterna-therapeutics-announces-92m-convertible-debt-and-warrant-financing
Eterna Therapeutics Announces $9.2M Conver...
12/15/2023 07:00:44

 Eterna Therapeutics Inc. a life science company committed to realizing the potential of mRNA cell engineering to provide patie...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
12/12/2023 17:31:12

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/07/2023 13:07:04

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
12/06/2023 21:31:12

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/01/2023 21:31:06

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
07/13/2023 21:38:44

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/02/2023 13:07:03

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
05/26/2023 17:31:33

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
05/19/2023 17:59:37

  On Friday, 63 companies hit new 52-week lows.

eterna-therapeutics-and-factor-bioscience-announce-new-data-on-multi-cell-type-therapeutic-approach-at-american-society-of-gene--cell-therapy-26th-annual-meeting
Eterna Therapeutics And Factor Bioscience ...
05/17/2023 12:46:07

Approach is potentially first iPS cell-derived multi-cell-type therapeutic strategy designed to mimic how the human immune syst...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/04/2023 13:06:58

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION